|
||
| |||||||
|
Disease Management Online: Web-based Tools for Patients Introduction Trials in online disease management (DM) tools have shown that patients with certain conditions who participate in DM programs notably improve their health, resulting in reduced costs of healthcare through lower mortality rates and fewer days in the hospital. This report examines the opportunities for investment in DM tools and how stakeholders can work together to meet their objectives. Scope Examines the provision of online DM tools by various stakeholders, including secondary care organizations, health plans and pharmaceutical companies Looks at the provision of tools to support differing levels of patient and clinical disease management Considers the challenges facing the online disease management market such as how to identify and target patients and how best to demonstrate ROI
Explores factors driving the adoption of online DM tools including the growing use of mobile technology and the use of DM tools in clinical trials Report Highlights The software used in online DM programs no longer necessitates the use of PC-based technology; programs are being developed for PDAs, televisions, cellular phones, network devices and potentially even gaming stations. The capture and management of clinical trial data are a sizeable component of the clinical trial process in terms of time and cost. Complementing electronic patient diaries with DM programs will help reduce costs and improve process efficiencies. Online DM programs generally require a substantial amount of self-management from patients; without their buy-in, the effectiveness of these programs is severely limited for all the stakeholders. However, a challenge lies in improving patient compliance in terms of managing their condition. Reasons to Purchase Identify the roles of relationships between the various stakeholders in the online DM market Understand the various demands on online DM tools in meeting the requirements of patients and physicians Recognize the future drivers in the online DM market and how they will impact the decision-making process Online DM from pharmaceutical companies 16 Solvay and Mycysticfibrosis.com 17 Supporting disease management tools 18 Tools to improve compliance 19 Efficacious treatments 20 Debilitating side effects 21 Asymptomatic conditions 21 Creating a social support network 22 Major lifestyle changes 22 Chronic conditions 23 Supporting caregivers 24 Challenges for stakeholders 26 Identifying and targeting patients 26 Use of modeling programs 26 Stakeholders without patient data 27 Operational execution 27 Security of patient information 28 Security regulations in the US 28 Security regulations in Europe 29 Security and consumers 29 Changing patient behavior 29 Demonstrating ROI 30 THE FUTURE DECODED 31 Raised awareness of self-managed DM tools among physicians 31 Developments in mobile disease management tools in professional monitoring 32 Use of DM programs in clinical trials 33 APPENDIX 35 List of figures 35 Methodology 35 Physician Insight Survey 2003 35 References 36 How to contact experts in your industry 37 December 2003, 37 pages Publisher: Datamonitor eHealthcare Pharma Reports To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_eHealthcare_Pharma.html#a281 |
|
|
